Today the TuAnalyze team launched two new surveys to learn about your device use experiences, problems and malfunctions. These surveys respond to a compelling need to create direct channels of communication between consumers—who individually and collectively have insight into the performance of devices (much of which goes untapped)—and the U.S. Food and Drug Administration (FDA), the agency charged with supporting consumer safety. If you use an insulin pump, insulin pen, glucose monitor or continuous glucose monitor, please take a few minutes to share your experiences by taking these surveys here. Today’s launch will help us learn about device performance and about the feasibility of collecting reports directly from you, the consumer.
To create these surveys, investigators at Children’s Hospital Boston and TuDiabetes staff worked with the FDA. Results from these surveys will be shared anonymously with the TuDiabetes community and with the FDA who will use these aggregated data to complement analyses of their traditional voluntary reports. We take privacy and data security seriously. Survey data are collected using the TuAnalyze application with full associated protections including encryption.
Thank you for your participation. If you have thoughts about this project or questions about these surveys, let the TuAnalyze team know by commenting below or sending an email to TuAnalyze@chip.org.